Login / Signup

Early inhaled budesonide in extremely preterm infants decreases long-term respiratory morbidity.

Jana TukovaJan SmisekBlanka ZlatohlavkovaRichard PlavkaDaniela Markova
Published in: Pediatric pulmonology (2020)
Our study suggests that early inhaled budesonide was associated with the trend to the improvement of functional lung parameters and with a lower rate of symptoms of chronic lung disease within the first 2 years of life.
Keyphrases
  • preterm infants
  • cystic fibrosis